At Gate2Brain, we have found the key to unlocking the gate to the brain . We have developed a unique shuttle technology to cross the blood-brain barrier. A technology based on a set of peptides to allow the different therapeutic agents to reach the brain in a non-invasive form.
Our first target is pediatric high grades gliomas which is a group of non-curable and fast acting CNS disorders. Gate2Brain’s technology can be applied to other molecules and to other brain diseases. Gate2Brain holds the potential to treat some of the most devastating human diseases.
We are working to bring this technology to the market and go beyond barriers.